Goldman says S&P can surpass 3,600

Goldman says S&P can surpass 3,600
The potential for an early vaccine and the outlook for U.S. growth mean there's room for stocks to go higher, analysts say
AUG 14, 2020
By  Bloomberg

U.S. stocks likely have more upside as they factor in American growth prospects and the COVID-19 vaccine outlook, according to Goldman Sachs Group Inc.

The implied level of the S&P 500 could be above 3,600, strategists Dominic Wilson and Vickie Chang wrote in a note Thursday. That’s if markets move toward Goldman’s “comparatively more optimistic” U.S. growth forecast, and real yields move higher but then further optimism pushes breakeven inflation rates higher without sending nominal yields up significantly, bringing the real yields down, they said.

The S&P closed at 3,373.43 on Thursday.

“There is still room for market pricing of U.S. growth views to move higher, particularly given improving prospects for an early vaccine,” the note said. “While a back-up in real yields would be a potential drag on equity returns, as long as it is driven by an upgrade to the market’s cyclical views, the improved cyclical outlook would dominate the effect of rising real yields and drive equities higher.”

The S&P 500 has risen 51% off its March 23 low as governments and central banks pumped liquidity into economies worldwide to mitigate the impact of the coronavirus pandemic.

Market strategists including Yardeni Research’s Ed Yardeni and Fundstrat Global Research’s Tom Lee have recently boosted their year-end estimates for the benchmark.

Latest News

Financial advisors, what is your volatility game plan for client management?
Financial advisors, what is your volatility game plan for client management?

With targeted "comfort calls" and strategically automated follow-ups, advisors who leverage their CRM systems effectively can show up when clients need them most.

Trump eyes no taxes for Americans making less than $150k, says Lutnick
Trump eyes no taxes for Americans making less than $150k, says Lutnick

The plan could offer $24,000 in relief for some taxpayers, but experts warn of consequences.

No new trial for convicted GPB Capital executives
No new trial for convicted GPB Capital executives

"I've seen lots of denial in this business but this GPB thing take the cake," says one industry executive.

BlackRock-led deal for Panama Ports draws ire from China
BlackRock-led deal for Panama Ports draws ire from China

Commentary from state-owned publication blasts sale to investor consortium as "spineless groveling," denting Hong Kong-based firm's stock.

Gold soars past $3,000 as Trump turbocharges record rally
Gold soars past $3,000 as Trump turbocharges record rally

Higher interest rates and a strong US dollar, which traditionally act as headwinds, haven't deterred market-stung investors from seeking refuge in the yellow metal.

SPONSORED Beyond the all-in-one: Why specialization is key in wealth tech

In an industry of broad solutions, firms like intelliflo prove 'you just need tools that play well together'

SPONSORED Record growth: Interval funds emerge as key players in alternative investments

Blue Vault Alts Summit highlights the role of liquidity-focused funds in reshaping advisor strategies